PYC pyc therapeutics limited

0.40%

$1.27

That would be great WW, but unfortunately so far initial success...

First 2 Last

Share
Profile

Follow
Heskumdai

2,359 Posts.

776

24/11/15

09:26

Post #: 16461449
Share

Originally posted by waynesworld ↑

A panel of eminent researchers sit down and construct a list of seven grand cancer challenges. Of course one challenge is to design a drug that will block MYC, the 'undruggable' target.

To be truly grand the task must be ambitious but not impossible. Richard Klausner, chair of the CRUK challenge-selection committee said that the challenges have been set at the edge of doable.

It would appear that Phylogica is working on the edge of doable with some worthwhile results-to-date. Whether, it lodges an application for the Grand Challenge itself, is unknown. What is known, however, is its strategy in defining an externally facilitated process which somewhat coincidentally replicates the team approach favoured in the Grand Challenge model.

CRUK has very successfully shone the spotlight on MYC. The research by Phylogica will be watched with great interest and early success will not go unnoticed.

Expand

That would be great WW, but unfortunately so far initial success has gone totally unnoticed - at least according to the SP.

Whoever said patience was a virtue was not an investor in PYC...!!

PYC Price at posting: 1.7¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

First 2 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.27		Change 0.005(0.40%)		Mkt cap ! $740.7M

Open	High	Low	Value	Volume
$1.27	$1.29	$1.27	$406.0K	319.3K

Buyers (Bids)

No.	Vol.	Price($)
1	13987	$1.27

Sellers (Offers)

Price($)	Vol.	No.
$1.29	1380	1

View Market Depth

No.	Vol.	Price($)
1	13987	1.265
1	15000	1.260
1	12000	1.255
1	4000	1.225
1	20000	1.220

Price($)	Vol.	No.
1.290	25630	2
1.295	24500	1
1.300	59168	4
1.325	9001	1
1.330	20000	2

Last trade - 16.10pm 27/06/2025 (20 minute delay)

PYC (ASX) Chart

That would be great WW, but unfortunately so far initial success...

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

That would be great WW, but unfortunately so far initial success...

Top Stories

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News